Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.510
-0.020 (-0.79%)
Oct 17, 2025, 4:10 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 488.11 million as of October 17, 2025. Its market cap has decreased by -34.08% in one year.
Market Cap
488.11M
Enterprise Value
756.99M
Revenue
741.27M
Ranking
n/a
PE Ratio
14.72
Stock Price
2.51
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 488.11M, a decrease of -29.29%. That is a compound annual growth rate of -7.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 488.11M | -28.69% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | 690.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 105.61B |
| Pro Medicus | 29.85B |
| Cochlear | 18.68B |
| Sonic Healthcare | 10.71B |
| Ramsay Health Care | 7.27B |
| Telix Pharmaceuticals | 5.63B |
| Ansell | 4.82B |
| Mesoblast | 3.35B |